speb/financial-data huggingface dataset:
NURS.V cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -167324.00
NURS.V income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -4078.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -151931.00
NURS.V income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1489773.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 1978464.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Gross PPE: 2777.00
NURS.V income_statement (quarterly, 2025-06-30) — Gross Profit: 1930202.00
NURS.V income_statement (quarterly, 2025-06-30) — Insurance And Claims: 26498.00
NURS.V income_statement (quarterly, 2025-06-30) — Interest Income: 43113.00
NURS.V income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 43113.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Invested Capital: 3413485.00
NURS.V cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -381535.00
NURS.V cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
NURS.V cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
NURS.V income_statement (quarterly, 2025-06-30) — Net Income: 49867.00
NURS.V income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 49867.00
NURS.V income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 49867.00
NURS.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 49867.00
NURS.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 49867.00
NURS.V cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 49867.00
NURS.V income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 49867.00
NURS.V cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -380761.00
NURS.V income_statement (quarterly, 2025-06-30) — Net Interest Income: -158888.00
NURS.V income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -158888.00
NURS.V cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -20754.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Net PPE: 2777.00
NURS.V cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -774.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 1435021.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 5842.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 5842.00
NURS.V income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 324040.00
NURS.V income_statement (quarterly, 2025-06-30) — Normalized Income: 53333.30
NURS.V cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 214211.00
NURS.V income_statement (quarterly, 2025-06-30) — Operating Income: 212833.00
NURS.V income_statement (quarterly, 2025-06-30) — Operating Revenue: 5376519.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 45210358.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -151931.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 1485439.00
NURS.V income_statement (quarterly, 2025-06-30) — Other Gand A: 793689.00
NURS.V income_statement (quarterly, 2025-06-30) — Other Income Expense: -4078.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 1978464.00
NURS.V income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 50330.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Other Payable: 553014.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Other Properties: 2777.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Payables: 2109627.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 2273136.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 273371.00
NURS.V income_statement (quarterly, 2025-06-30) — Pretax Income: 49867.00
NURS.V cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 78669.00
NURS.V cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -380761.00
NURS.V cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -774.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Receivables: 284161.00
NURS.V income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 3446317.00
NURS.V income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 107129.00
NURS.V income_statement (quarterly, 2025-06-30) — Rent And Landing Fees: 54670.00
NURS.V income_statement (quarterly, 2025-06-30) — Rent Expense Supplemental: 54670.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -9059866.00
NURS.V income_statement (quarterly, 2025-06-30) — Salaries And Wages: 614916.00
NURS.V income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 70137.00
NURS.V income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1559910.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Share Issued: 45210358.00
NURS.V cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 24975.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 3413485.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1435021.00
NURS.V income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -611.70
NURS.V income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.15
NURS.V balance_sheet (quarterly, 2025-06-30) — Total Assets: 8642891.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 3413485.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 3413485.00
NURS.V income_statement (quarterly, 2025-06-30) — Total Expenses: 5163686.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 5229406.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1981241.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 755721.00
NURS.V income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 202001.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 443667.00
NURS.V income_statement (quarterly, 2025-06-30) — Total Unusual Items: -4078.00
NURS.V income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -4078.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 0.00
NURS.V balance_sheet (quarterly, 2025-06-30) — Working Capital: 2187965.00
NURS.V income_statement (quarterly, 2025-09-30) — +Operating Expense: 1642018.00
NURS.V income_statement (quarterly, 2025-09-30) — +Total Revenue: 10519538.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 553966.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 345461.00
NURS.V income_statement (quarterly, 2025-09-30) — Basic Average Shares: 47264156.00
NURS.V income_statement (quarterly, 2025-09-30) — Basic EPS: 0.01
NURS.V cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 6104118.00
NURS.V cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -379562.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Capital Stock: 15058830.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 18635165.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 18635165.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Cash Financial: 18635165.00
NURS.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 13690134.00
NURS.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -679562.00
NURS.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -311642.00
NURS.V cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -341479.00
NURS.V cash_flow (quarterly, 2025-09-30) — Change In Inventory: 0.00
NURS.V cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 159120.00
NURS.V cash_flow (quarterly, 2025-09-30) — Change In Payable: -341479.00
NURS.V cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -341479.00
NURS.V cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -597859.00
NURS.V cash_flow (quarterly, 2025-09-30) — Change In Receivables: -151176.00
NURS.V cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -931394.00
NURS.V cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -149398.00
NURS.V cash_flow (quarterly, 2025-09-30) — Changes In Cash: 12698930.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Common Stock: 15058830.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 9473056.00
NURS.V cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
NURS.V income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 8189218.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 314111.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Current Assets: 19963348.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 2357564.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 2357564.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 4466790.00
NURS.V cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 116657.00
NURS.V income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 116657.00
NURS.V cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 116657.00
NURS.V income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 116657.00
NURS.V income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 48464992.00
NURS.V income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.01
NURS.V income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 361888.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Duefrom Related Parties Current: 81037.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Non Current: 430539.00
NURS.V income_statement (quarterly, 2025-09-30) — EBIT: 496033.00
NURS.V income_statement (quarterly, 2025-09-30) — EBITDA: 612690.00
NURS.V cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -167883.00
NURS.V cash_flow (quarterly, 2025-09-30) — End Cash Position: 18635165.00
NURS.V cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 13690134.00
NURS.V cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -691204.00
NURS.V income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -1103.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -271502.00
NURS.V income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 1412848.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 2303489.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Gross PPE: 2327.00
NURS.V income_statement (quarterly, 2025-09-30) — Gross Profit: 2330320.00
NURS.V income_statement (quarterly, 2025-09-30) — Insurance And Claims: 26429.00
NURS.V income_statement (quarterly, 2025-09-30) — Interest Expense: 134145.00
NURS.V income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 134145.00
NURS.V income_statement (quarterly, 2025-09-30) — Interest Income: 80922.00
NURS.V income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 80922.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Interest Payable: 73726.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Invested Capital: 17363889.00
NURS.V cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -679562.00
NURS.V cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 7890833.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 7890833.00
NURS.V cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
NURS.V income_statement (quarterly, 2025-09-30) — Net Income: 361888.00
NURS.V income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 361888.00
NURS.V income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 361888.00
NURS.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 361888.00
NURS.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 361888.00
NURS.V cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 361888.00
NURS.V income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 361888.00
NURS.V cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -379562.00
NURS.V income_statement (quarterly, 2025-09-30) — Net Interest Income: -325311.00
NURS.V income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -325311.00
NURS.V cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -33470.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Net PPE: 2327.00
NURS.V cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 0.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 7169567.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 7946.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 7946.00
NURS.V income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 613793.00
NURS.V income_statement (quarterly, 2025-09-30) — Normalized Income: 362825.55
NURS.V cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -311642.00
NURS.V income_statement (quarterly, 2025-09-30) — Operating Income: 688302.00
NURS.V income_statement (quarterly, 2025-09-30) — Operating Revenue: 10519538.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 47264156.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -271502.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 3383706.00
NURS.V income_statement (quarterly, 2025-09-30) — Other Gand A: 701849.00
NURS.V income_statement (quarterly, 2025-09-30) — Other Income Expense: -1103.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 2303489.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Other Payable: 788441.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Other Properties: 2327.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Other Receivables: 23949.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Payables: 1795115.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 2109226.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 871229.00
NURS.V income_statement (quarterly, 2025-09-30) — Pretax Income: 361888.00
NURS.V cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 3100522.00
NURS.V cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -379562.00
NURS.V cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: 0.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Receivables: 456954.00
NURS.V income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 8189218.00
NURS.V income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 116657.00
NURS.V income_statement (quarterly, 2025-09-30) — Rent And Landing Fees: 68623.00
NURS.V income_statement (quarterly, 2025-09-30) — Rent Expense Supplemental: 68623.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -8697978.00
NURS.V income_statement (quarterly, 2025-09-30) — Salaries And Wages: 615947.00
NURS.V income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 112513.00
NURS.V income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1525361.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Share Issued: 47264156.00
NURS.V cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 7062.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 9473056.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 7169567.00
NURS.V income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -165.45
NURS.V income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.15
NURS.V balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 6507.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Total Assets: 22269164.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 17363889.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Total Debt: 7890833.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 9473056.00
NURS.V income_statement (quarterly, 2025-09-30) — Total Expenses: 9831236.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 12796108.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 2305816.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 8329318.00
NURS.V income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 272088.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 452708.00
NURS.V income_statement (quarterly, 2025-09-30) — Total Unusual Items: -1103.00
NURS.V income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -1103.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Tradeand Other Payables Non Current: 0.00
NURS.V balance_sheet (quarterly, 2025-09-30) — Working Capital: 15496558.00
NURS.V income_statement (annual, 2025-12-31) — +Operating Expense: 6790547.00
NURS.V income_statement (quarterly, 2025-12-31) — +Operating Expense: 2005493.00
NURS.V income_statement (annual, 2025-12-31) — +Total Revenue: 35385038.00
NURS.V income_statement (quarterly, 2025-12-31) — +Total Revenue: 14948859.00
NURS.V balance_sheet (annual, 2025-12-31) — Accounts Payable: 1299761.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1299761.00
NURS.V balance_sheet (annual, 2025-12-31) — Accounts Receivable: 1682712.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 1682712.00
NURS.V cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 54814.00
NURS.V income_statement (annual, 2025-12-31) — Basic Average Shares: 45337028.00
NURS.V income_statement (annual, 2025-12-31) — Basic EPS: 0.04
NURS.V cash_flow (annual, 2025-12-31) — Beginning Cash Position: 1186942.00
NURS.V cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 18635165.00
NURS.V cash_flow (annual, 2025-12-31) — Capital Expenditure: -1515049.00
NURS.V cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -418677.00
NURS.V balance_sheet (annual, 2025-12-31) — Capital Stock: 25094908.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Capital Stock: 25094908.00
NURS.V balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 15649232.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 15649232.00
NURS.V balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 15649232.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 15649232.00
NURS.V cash_flow (annual, 2025-12-31) — Cash Dividends Paid: 0.00
NURS.V balance_sheet (annual, 2025-12-31) — Cash Financial: 15649232.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Cash Financial: 15649232.00
NURS.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 18002543.00
NURS.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -578626.00
NURS.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1679041.00
NURS.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -282669.00
NURS.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -1866263.00
NURS.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -2123151.00
NURS.V cash_flow (annual, 2025-12-31) — Change In Account Payable: 374910.00
NURS.V cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 793336.00
NURS.V cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: 119249.00
NURS.V cash_flow (annual, 2025-12-31) — Change In Inventory: 0.00
NURS.V cash_flow (quarterly, 2025-12-31) — Change In Inventory: 0.00
NURS.V cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 433992.00
NURS.V cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -196713.00
NURS.V cash_flow (annual, 2025-12-31) — Change In Payable: 494159.00
NURS.V cash_flow (quarterly, 2025-12-31) — Change In Payable: 912585.00
NURS.V cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 494159.00
NURS.V cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 912585.00
NURS.V cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -3317225.00
NURS.V cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -2674830.00
NURS.V cash_flow (annual, 2025-12-31) — Change In Receivables: -1645016.00
NURS.V cash_flow (quarterly, 2025-12-31) — Change In Receivables: -1366885.00
NURS.V cash_flow (annual, 2025-12-31) — Change In Tax Payable: 119249.00
NURS.V cash_flow (annual, 2025-12-31) — Change In Working Capital: -4034090.00
NURS.V cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -3325843.00
NURS.V cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -1645016.00
NURS.V cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -1342028.00
NURS.V cash_flow (annual, 2025-12-31) — Changes In Cash: 14457239.00
NURS.V cash_flow (quarterly, 2025-12-31) — Changes In Cash: -2984446.00
NURS.V balance_sheet (annual, 2025-12-31) — Common Stock: 25094908.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Common Stock: 25094908.00
NURS.V balance_sheet (annual, 2025-12-31) — Common Stock Equity: 19699444.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 19699444.00
NURS.V cash_flow (annual, 2025-12-31) — Common Stock Issuance: 4796987.00
NURS.V cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
NURS.V cash_flow (annual, 2025-12-31) — Common Stock Payments: 0.00
NURS.V income_statement (annual, 2025-12-31) — Cost Of Revenue: 26381832.00
NURS.V income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 11710640.00
NURS.V balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 317456.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 317456.00
NURS.V balance_sheet (annual, 2025-12-31) — Current Assets: 20946300.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Current Assets: 20946300.00
NURS.V balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 2145738.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 2145738.00
NURS.V balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 2145738.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 2145738.00
NURS.V balance_sheet (annual, 2025-12-31) — Current Liabilities: 5259758.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 5259758.00
NURS.V cash_flow (annual, 2025-12-31) — Deferred Income Tax: -699586.00
NURS.V cash_flow (annual, 2025-12-31) — Deferred Tax: -699586.00
NURS.V cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 452772.00
NURS.V cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 127982.00
NURS.V income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 452772.00
NURS.V income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 127982.00
NURS.V cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 452772.00
NURS.V cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 127982.00
NURS.V income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 452772.00
NURS.V income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 127982.00
NURS.V income_statement (annual, 2025-12-31) — Diluted Average Shares: 46864568.00
NURS.V income_statement (annual, 2025-12-31) — Diluted EPS: 0.04
NURS.V income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 1694304.00
NURS.V income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 1261646.00
NURS.V balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Current: 83020.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Current: 83020.00
NURS.V balance_sheet (annual, 2025-12-31) — Dueto Related Parties Non Current: 412716.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Non Current: 412716.00
NURS.V income_statement (annual, 2025-12-31) — EBIT: 1700321.00
NURS.V income_statement (quarterly, 2025-12-31) — EBIT: 1133518.00
NURS.V income_statement (annual, 2025-12-31) — EBITDA: 2153093.00
NURS.V income_statement (quarterly, 2025-12-31) — EBITDA: 1261500.00
NURS.V income_statement (annual, 2025-12-31) — Earnings From Equity Interest: 3216.00
NURS.V cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: -3216.00
NURS.V cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 5051.00
NURS.V cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -1487.00
NURS.V cash_flow (annual, 2025-12-31) — End Cash Position: 15649232.00
NURS.V cash_flow (quarterly, 2025-12-31) — End Cash Position: 15649232.00
NURS.V cash_flow (annual, 2025-12-31) — Financing Cash Flow: 18002543.00
NURS.V cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -578626.00
NURS.V cash_flow (annual, 2025-12-31) — Free Cash Flow: -3381312.00
NURS.V cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -2541828.00
NURS.V income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -10263.00
NURS.V income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -248.00
NURS.V balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -319311.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -319311.00
NURS.V income_statement (annual, 2025-12-31) — General And Administrative Expense: 5650430.00
NURS.V income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1550692.00
NURS.V balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 2535140.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 2535140.00
NURS.V balance_sheet (annual, 2025-12-31) — Gross PPE: 2686.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Gross PPE: 2686.00
NURS.V income_statement (annual, 2025-12-31) — Gross Profit: 9003206.00
NURS.V income_statement (quarterly, 2025-12-31) — Gross Profit: 3238219.00
NURS.V income_statement (annual, 2025-12-31) — Insurance And Claims: 105284.00
NURS.V income_statement (quarterly, 2025-12-31) — Insurance And Claims: 24630.00
NURS.V income_statement (annual, 2025-12-31) — Interest Expense: 586354.00
NURS.V income_statement (quarterly, 2025-12-31) — Interest Expense: 452209.00
NURS.V income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 586354.00
NURS.V income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 452209.00
NURS.V income_statement (annual, 2025-12-31) — Interest Income: 367599.00
NURS.V income_statement (quarterly, 2025-12-31) — Interest Income: 144836.00
NURS.V income_statement (annual, 2025-12-31) — Interest Income Non Operating: 367599.00
NURS.V income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 144836.00
NURS.V cash_flow (annual, 2025-12-31) — Interest Paid Cff: -336375.00
NURS.V balance_sheet (annual, 2025-12-31) — Invested Capital: 28056280.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Invested Capital: 28056280.00
NURS.V cash_flow (annual, 2025-12-31) — Investing Cash Flow: -1679041.00
NURS.V cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -282669.00
NURS.V balance_sheet (annual, 2025-12-31) — Investments And Advances: 10267689.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 10267689.00
NURS.V balance_sheet (annual, 2025-12-31) — Investmentsin Associatesat Cost: 10267689.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Investmentsin Associatesat Cost: 10267689.00
NURS.V cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 4796987.00
NURS.V cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
NURS.V cash_flow (annual, 2025-12-31) — Issuance Of Debt: 10506434.00
NURS.V cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: -116648.00
NURS.V balance_sheet (annual, 2025-12-31) — Long Term Debt: 8356836.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 8356836.00
NURS.V balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 8356836.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 8356836.00
NURS.V cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 10506434.00
NURS.V cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: -116648.00
NURS.V balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 10267689.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 10267689.00
NURS.V cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 4796987.00
NURS.V cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
NURS.V income_statement (annual, 2025-12-31) — Net Income: 1694304.00
NURS.V income_statement (quarterly, 2025-12-31) — Net Income: 1261646.00
NURS.V income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 1694304.00
NURS.V income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 1261646.00
NURS.V income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 1694304.00
NURS.V income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 1261646.00
NURS.V income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1694304.00
NURS.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1261646.00
NURS.V income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1694304.00
NURS.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1261646.00
NURS.V cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 1694304.00
NURS.V cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 1261646.00
NURS.V income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 1694304.00
NURS.V income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 1261646.00
NURS.V cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -1512147.00
NURS.V cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -417770.00
NURS.V income_statement (annual, 2025-12-31) — Net Interest Income: -1036831.00
NURS.V income_statement (quarterly, 2025-12-31) — Net Interest Income: -499571.00
NURS.V cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 10506434.00
NURS.V cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -116648.00
NURS.V cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 10506434.00
NURS.V cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -116648.00
NURS.V income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -1036831.00
NURS.V income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -499571.00
NURS.V cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -383354.00
NURS.V cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -307602.00
NURS.V cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -163992.00
NURS.V cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 136008.00
NURS.V balance_sheet (annual, 2025-12-31) — Net PPE: 2686.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Net PPE: 2686.00
NURS.V cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -2902.00
NURS.V cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -907.00
NURS.V balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 17164304.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 17164304.00
NURS.V balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 23060.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 23060.00
NURS.V balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 23060.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 23060.00
NURS.V income_statement (annual, 2025-12-31) — Normalized EBITDA: 2218170.00
NURS.V income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 1316562.00
NURS.V income_statement (annual, 2025-12-31) — Normalized Income: 1749619.45
NURS.V income_statement (quarterly, 2025-12-31) — Normalized Income: 1308448.70
NURS.V cash_flow (annual, 2025-12-31) — Operating Cash Flow: -1866263.00
NURS.V cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -2123151.00
NURS.V cash_flow (annual, 2025-12-31) — Operating Gains Losses: -3216.00
NURS.V income_statement (annual, 2025-12-31) — Operating Income: 2212659.00
NURS.V income_statement (quarterly, 2025-12-31) — Operating Income: 1232726.00
NURS.V income_statement (annual, 2025-12-31) — Operating Revenue: 35385038.00
NURS.V income_statement (quarterly, 2025-12-31) — Operating Revenue: 14948859.00
NURS.V balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 49629018.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 49629018.00
NURS.V balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -319311.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -319311.00
NURS.V balance_sheet (annual, 2025-12-31) — Other Equity Interest: 2360179.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 2360179.00
NURS.V income_statement (annual, 2025-12-31) — Other Gand A: 2924126.00
NURS.V income_statement (quarterly, 2025-12-31) — Other Gand A: 881677.00
NURS.V income_statement (annual, 2025-12-31) — Other Income Expense: -61861.00
NURS.V income_statement (quarterly, 2025-12-31) — Other Income Expense: -51846.00
NURS.V balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 2535140.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 2535140.00
NURS.V cash_flow (annual, 2025-12-31) — Other Non Cash Items: 586354.00
NURS.V cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 452209.00
NURS.V income_statement (annual, 2025-12-31) — Other Operating Expenses: 352539.00
NURS.V income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 250774.00
NURS.V balance_sheet (annual, 2025-12-31) — Other Payable: 779973.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Other Payable: 779973.00
NURS.V balance_sheet (annual, 2025-12-31) — Other Properties: 2686.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Other Properties: 2686.00
NURS.V balance_sheet (annual, 2025-12-31) — Other Receivables: 62285.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Other Receivables: 62285.00
NURS.V balance_sheet (annual, 2025-12-31) — Payables: 2796564.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Payables: 2796564.00
NURS.V balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 3114020.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 3114020.00
NURS.V balance_sheet (annual, 2025-12-31) — Prepaid Assets: 3491245.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 3491245.00
NURS.V income_statement (annual, 2025-12-31) — Pretax Income: 1113967.00
NURS.V income_statement (quarterly, 2025-12-31) — Pretax Income: 681309.00
NURS.V cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 3418851.00
NURS.V cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 181999.00
NURS.V cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -1512147.00
NURS.V cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -417770.00
NURS.V cash_flow (annual, 2025-12-31) — Purchase Of PPE: -2902.00
NURS.V cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -907.00
NURS.V balance_sheet (annual, 2025-12-31) — Receivables: 1805823.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Receivables: 1805823.00
NURS.V balance_sheet (annual, 2025-12-31) — Receivables Adjustments Allowances: -28178.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Receivables Adjustments Allowances: -28178.00
NURS.V income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 26381832.00
NURS.V income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 11710640.00
NURS.V income_statement (annual, 2025-12-31) — Reconciled Depreciation: 452772.00
NURS.V income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 127982.00
NURS.V income_statement (annual, 2025-12-31) — Rent And Landing Fees: 215903.00
NURS.V income_statement (quarterly, 2025-12-31) — Rent And Landing Fees: 24394.00
NURS.V income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 215903.00
NURS.V income_statement (quarterly, 2025-12-31) — Rent Expense Supplemental: 24394.00
NURS.V cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: 0.00
NURS.V balance_sheet (annual, 2025-12-31) — Retained Earnings: -7436332.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -7436332.00
NURS.V income_statement (annual, 2025-12-31) — Salaries And Wages: 2405117.00
NURS.V income_statement (quarterly, 2025-12-31) — Salaries And Wages: 619991.00
NURS.V income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 334806.00
NURS.V income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 76045.00
NURS.V income_statement (annual, 2025-12-31) — Selling General And Administration: 5985236.00
NURS.V income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1626737.00
NURS.V balance_sheet (annual, 2025-12-31) — Share Issued: 49629018.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Share Issued: 49629018.00
NURS.V income_statement (annual, 2025-12-31) — Special Income Charges: -54814.00
NURS.V cash_flow (annual, 2025-12-31) — Stock Based Compensation: 82385.00
NURS.V cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 8843.00
NURS.V balance_sheet (annual, 2025-12-31) — Stockholders Equity: 19699444.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 19699444.00
NURS.V balance_sheet (annual, 2025-12-31) — Tangible Book Value: 17164304.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 17164304.00
NURS.V income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -9761.55
NURS.V income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -8259.30
NURS.V income_statement (annual, 2025-12-31) — Tax Provision: -580337.00
NURS.V income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.15
NURS.V income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.15
NURS.V balance_sheet (annual, 2025-12-31) — Taxes Receivable: 5984.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 5984.00
NURS.V balance_sheet (annual, 2025-12-31) — Total Assets: 33751814.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Total Assets: 33751814.00
NURS.V balance_sheet (annual, 2025-12-31) — Total Capitalization: 28056280.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 28056280.00
NURS.V balance_sheet (annual, 2025-12-31) — Total Debt: 8356836.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Total Debt: 8356836.00
NURS.V balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 19699444.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 19699444.00
NURS.V income_statement (annual, 2025-12-31) — Total Expenses: 33172379.00
NURS.V income_statement (quarterly, 2025-12-31) — Total Expenses: 13716133.00
NURS.V balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 14052370.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 14052370.00
NURS.V balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 12805515.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 12805515.00
NURS.V balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 8792612.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 8792612.00
NURS.V income_statement (annual, 2025-12-31) — Total Other Finance Cost: 818076.00
NURS.V income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 192198.00
NURS.V balance_sheet (annual, 2025-12-31) — Total Tax Payable: 716830.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 716830.00
NURS.V income_statement (annual, 2025-12-31) — Total Unusual Items: -65077.00
NURS.V income_statement (quarterly, 2025-12-31) — Total Unusual Items: -55062.00
NURS.V income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -65077.00
NURS.V income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -55062.00
NURS.V balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 0.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 0.00
NURS.V balance_sheet (annual, 2025-12-31) — Working Capital: 15686542.00
NURS.V balance_sheet (quarterly, 2025-12-31) — Working Capital: 15686542.00
NURS.V income_statement (annual, 2025-12-31) — Write Off: 54814.00
NURS.V income_statement (quarterly, 2026-03-31) — +Operating Expense: 1943754.00
NURS.V income_statement (quarterly, 2026-03-31) — +Total Revenue: 24930651.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1288233.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 10659184.00
NURS.V income_statement (quarterly, 2026-03-31) — Basic Average Shares: 52267644.00
NURS.V income_statement (quarterly, 2026-03-31) — Basic EPS: 0.05
NURS.V cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 15649232.00
NURS.V cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -359861.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Capital Stock: 35311620.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 24212134.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 24212134.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Cash Financial: 24212134.00
NURS.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 13795703.00
NURS.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -509861.00
NURS.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -4865009.00
NURS.V cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 314703.00
NURS.V cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 844554.00
NURS.V cash_flow (quarterly, 2026-03-31) — Change In Payable: 506703.00
NURS.V cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 506703.00
NURS.V cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -463402.00
NURS.V cash_flow (quarterly, 2026-03-31) — Change In Receivables: -8960195.00
NURS.V cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -8072340.00
NURS.V cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -8960195.00
NURS.V cash_flow (quarterly, 2026-03-31) — Changes In Cash: 8420833.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Common Stock: 35311620.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 36406622.00
NURS.V cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 13760680.00
NURS.V income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 19848247.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 738271.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Current Assets: 38943836.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 3002269.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 3002269.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 6920556.00
NURS.V cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 174217.00
NURS.V income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 174217.00
NURS.V cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 174217.00
NURS.V income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 174217.00
NURS.V income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 53717546.00
NURS.V income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.05
NURS.V income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 2586742.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 96160.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 192000.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Non Current: 391883.00
NURS.V income_statement (quarterly, 2026-03-31) — EBIT: 3054305.00
NURS.V income_statement (quarterly, 2026-03-31) — EBITDA: 3228522.00
NURS.V income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: 26073.00
NURS.V cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: -26073.00
NURS.V cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 142069.00
NURS.V cash_flow (quarterly, 2026-03-31) — End Cash Position: 24212134.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 249260.00
NURS.V cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 13795703.00
NURS.V cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -5224870.00
NURS.V income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 3539.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -119696.00
NURS.V income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 1443294.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2806889.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Gross PPE: 5590.00
NURS.V income_statement (quarterly, 2026-03-31) — Gross Profit: 5082404.00
NURS.V income_statement (quarterly, 2026-03-31) — Insurance And Claims: 27594.00
NURS.V income_statement (quarterly, 2026-03-31) — Interest Expense: 467563.00
NURS.V income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 467563.00
NURS.V income_statement (quarterly, 2026-03-31) — Interest Income: 114424.00
NURS.V income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 114424.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Interest Payable: 255205.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Invested Capital: 44975816.00
NURS.V cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -509861.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 249260.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 10543022.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Investmentsin Associatesat Cost: 10293762.00
NURS.V cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 13760680.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 8569194.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 8569194.00
NURS.V balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 10293762.00
NURS.V cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 13760680.00
NURS.V income_statement (quarterly, 2026-03-31) — Net Income: 2586742.00
NURS.V income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 2586742.00
NURS.V income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 2586742.00
NURS.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 2586742.00
NURS.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 2586742.00
NURS.V cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 2586742.00